Aditxt Inc.

NASDAQ:ADTX USA Biotechnology
Market Cap
$328.56K
Market Cap Rank
#41171 Global
#13383 in USA
Share Price
$1.48
Change (1 day)
-8.64%
52-Week Range
$0.07 - $10.69
All Time High
$2200.00
About

Aditxt, Inc., a commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women's health, and neurologic health. The company develops AditxtScore that enable individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a n… Read more

Aditxt Inc. (ADTX) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.265x

Based on the latest financial reports, Aditxt Inc. (ADTX) has a cash flow conversion efficiency ratio of 0.265x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.34 Million) by net assets ($-8.86 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Aditxt Inc. - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Aditxt Inc. 's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Aditxt Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aditxt Inc. ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Aditxt Inc. (2017–2024)

The table below shows the annual cash flow conversion efficiency of Aditxt Inc. from 2017 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $8.29 Million $-16.76 Million -2.023x -74.73%
2023-12-31 $16.05 Million $-18.58 Million -1.158x +73.08%
2022-12-31 $5.21 Million $-22.39 Million -4.301x -96.55%
2021-12-31 $10.18 Million $-22.28 Million -2.188x -233.69%
2020-12-31 $11.01 Million $-7.22 Million -0.656x -502.79%
2019-12-31 $-2.85 Million $-464.35K 0.163x -35.23%
2018-12-31 $-1.54 Million $-386.26K 0.251x -96.10%
2017-12-31 $-59.90K $-386.26K 6.448x --